Addus HomeCare Corporation $ADUS Shares Acquired by Leeward Investments LLC MA

Leeward Investments LLC MA increased its stake in Addus HomeCare Corporation (NASDAQ:ADUS) by 9.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 120,857 shares of the company’s stock after purchasing an additional 10,414 shares during the period. Leeward Investments LLC MA’s holdings in Addus HomeCare were worth $11,318,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Capital Research Global Investors lifted its stake in Addus HomeCare by 22.3% in the fourth quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock valued at $157,837,000 after buying an additional 268,192 shares during the last quarter. Freestone Grove Partners LP lifted its position in Addus HomeCare by 5,035.2% in the 4th quarter. Freestone Grove Partners LP now owns 137,932 shares of the company’s stock valued at $14,813,000 after purchasing an additional 135,246 shares during the last quarter. 8 Knots Management LLC bought a new stake in Addus HomeCare in the 3rd quarter valued at about $6,075,000. Empowered Funds LLC boosted its stake in Addus HomeCare by 186.1% during the 4th quarter. Empowered Funds LLC now owns 70,927 shares of the company’s stock valued at $7,617,000 after purchasing an additional 46,137 shares during the period. Finally, Adage Capital Partners GP L.L.C. acquired a new position in Addus HomeCare during the 2nd quarter valued at about $4,838,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

Insiders Place Their Bets

In other news, insider Heather Brianne Dixon sold 288 shares of the firm’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the transaction, the insider owned 44,371 shares in the company, valued at approximately $4,160,668.67. This trade represents a 0.64% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 966 shares of company stock valued at $90,168. 4.10% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

ADUS has been the topic of several analyst reports. Wall Street Zen lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 21st. Weiss Ratings downgraded Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 22nd. Royal Bank Of Canada reiterated an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research report on Wednesday, February 25th. Stephens decreased their price target on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a research note on Wednesday, February 25th. Finally, Barclays lowered their price target on Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating on the stock in a report on Friday, May 15th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $131.00.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS opened at $96.09 on Wednesday. The stock has a market cap of $1.79 billion, a price-to-earnings ratio of 17.76, a PEG ratio of 1.30 and a beta of 0.89. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.83 and a quick ratio of 1.83. Addus HomeCare Corporation has a 12 month low of $87.95 and a 12 month high of $124.43. The stock’s 50 day moving average price is $94.05 and its 200 day moving average price is $101.97.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, May 4th. The company reported $1.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.52 by $0.10. The firm had revenue of $363.50 million during the quarter, compared to analyst estimates of $366.41 million. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The firm’s quarterly revenue was up 7.7% on a year-over-year basis. During the same period last year, the company posted $1.42 EPS. Equities research analysts anticipate that Addus HomeCare Corporation will post 6.24 earnings per share for the current fiscal year.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.